Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis - Long-term followup of a prospective clinical trial

被引:102
|
作者
Brinkman, D. M. C.
de Kleer, I. M.
ten Cate, R.
van Rossum, M. A. J.
Bekkering, W. P.
Fasth, A.
van Tol, M. J. D.
Kuis, W.
Wulffraat, N. M.
Vossen, J. M.
机构
[1] Leiden Univ, Med Ctr, Dept Paediat, NL-2300 RC Leiden, Netherlands
[2] Gothenburg Univ, S-41124 Gothenburg, Sweden
[3] Queen Silvia Childrens Hosp, S-41124 Gothenburg, Sweden
来源
ARTHRITIS AND RHEUMATISM | 2007年 / 56卷 / 07期
关键词
D O I
10.1002/art.22656
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To assess the safety and efficacy of intensive immunosuppression followed by T cell-depleted autologous hematopoietic stem cell transplantation (ASCT) for induction of disease remission in children with refractory progressive juvenile idiopathic arthritis (JIA). Methods. Twenty-two patients with progressive refractory JIA were followed up over a median period of 80 months after pretreatment with intensive immunosuppression followed by ASCT in a multicenter, prospective, phase II clinical trial. Hematopoietic stem cells were harvested from the patients' bone marrow, depleted of T cells, and kept frozen until used for ASCT. Pretreatment of patients consisted of a combination of antithymocyte globulin, cyclophosphamide, and low-dose total body irradiation. Patients were followed up for ASCT-related complications, recovery of hematologic and immune system parameters, and disease outcomes. Results. Reconstitution of hematologic values to normal range was rapid. Recovery of immune system parameters, especially normalization of CD4+, CD45RA+ naive T cells, was delayed, occurring at !6 months after ASCT. The prolonged period of immune deficiency resulted in a large number of viral infections and may have contributed to the development of macrophage activation syndrome (MAS), leading to death, in 2 patients. After ASCT, 8 of the 20 evaluable patients reached complete clinical remission of their JIA, 7 were partial responders, and 5 experienced a relapse of their disease (occurring 7 years after ASCT in 1 patient). Later during followup, 2 of the patients whose disease relapsed died from infections that developed after restarting immunosuppressive medication. Conclusion. Intensive immunosuppression followed by ASCT resulted in sustained complete remission or marked improvement in 15 of 22 patients with progressive refractory JIA. The procedure, however, is associated with significant morbidity and risk of mortality due to prolonged and severe depression of T cell immunity. After fatal complications due to NIAS were observed in some patients, the protocol was amended in 1999, to ensure less profound depletion of T cells, better control of systemic disease before transplantation, antiviral prophylaxis after transplantation, and slow tapering of corticosteroids. Following these protocol modifications, no additional ASCT-related deaths were observed among the 11 patients who received the modified treatment.
引用
收藏
页码:2410 / 2421
页数:12
相关论文
共 50 条
  • [21] Macrophage activation syndrome after autologous stem cell transplantation for systemic juvenile idiopathic arthritis
    Rebecca ten Cate
    Danielle M. Brinkman
    Marion A. van Rossum
    Arjan C. Lankester
    Robbert G. Bredius
    Maarten R. Egeler
    Maarten J. van Tol
    Jaak M. Vossen
    European Journal of Pediatrics, 2002, 161 : 685 - 686
  • [22] Long-Term Efficacy and Safety of Canakinumab in Children with Systemic Juvenile Idiopathic Arthritis
    Alexeeva, Ekaterina
    Denisova, Rina
    Dvoryakovskaya, Tatyana
    Isaeva, Ksenia
    Kriulin, Ivan
    Alshevskaya, Alina
    Moskalev, Andrey
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [23] Autologous stem cell transplantation for refractory juvenile idiopathic arthritis.
    Wulffraat, NM
    Brinkman, D
    Prieur, A
    ten Cate, RC
    van der Net, JJ
    Kamphuis, SSM
    Kuis, W
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S381 - S381
  • [24] LONG-TERM SAFETY AND EFFECTIVENESS OF ADALIMUMAB IN CHILDREN WITH MODERATELY TO SEVERELY ACTIVE POLYARTICULAR OR POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS
    Horneff, G.
    Ruperto, N.
    Wallace, C.
    Bereswill, M.
    Cardoso, A.
    Kalabic, J.
    Kupper, H.
    Brunner, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 61 - 62
  • [25] Long term follow up of immune repertoire after severe immunosuppression and autologous stem cell rescue in children with juvenile idiopathic arthritis.
    Wedderburn, LR
    Patel, A
    King, D
    Varsani, H
    Foster, HE
    Abinun, MM
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S98 - S99
  • [26] Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation
    Wulffraat, NM
    Rijkers, GT
    Elst, E
    Brooimans, R
    Kuis, W
    RHEUMATOLOGY, 2003, 42 (02) : 375 - 379
  • [27] LONG-TERM FOLLOW-UP OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR SEVERE SYSTEMIC SCLEROSIS
    Tsukamoto, H.
    Horiuchi, T.
    Miyamoto, T.
    Niiro, H.
    Arinobu, Y.
    Inoue, Y.
    Ayano, M.
    Tanaka, A.
    Ueda, N.
    Harada, M.
    Akashi, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 235 - 236
  • [28] Autologous T cell depleted haematopoietic stem cell transplantation in children with severe juvenile idiopathic arthritis in the UK (2000-2007)
    Abinun, Mario
    Flood, Terence J.
    Cant, Andrew J.
    Veys, Paul
    Gennery, Andrew R.
    Foster, Helen E.
    Friswell, Mark
    Baildam, Eileen
    Davidson, Joyce
    Southwood, Taunton R.
    Livermore, Polly
    Wedderburn, Lucy R.
    MOLECULAR IMMUNOLOGY, 2009, 47 (01) : 46 - 51
  • [29] LONG-TERM SAFETY AND EFFECTIVENESS OF ADALIMUMAB IN CHILDREN WITH MODERATELY TO SEVERELY ACTIVE POLYARTICULAR OR POLYARTICULAR-COURSE JUVENILE IDIOPATHIC ARTHRITIS Abstracts
    Ruperto, N.
    Brunner, H.
    Wallace, C.
    Toth, M.
    Foeldvari, I.
    Bohnsack, J.
    Milojevic, D.
    Rabinovich, E.
    Vavrincova, P.
    Kingsbury, D.
    Marzan, K.
    Quartier, P.
    Minden, K.
    Chalom, E.
    Horneff, G.
    Kuester, R. -M.
    Dare, J.
    Bereswill, M.
    Kupper, H.
    Kalabic, J.
    Martini, A.
    Lovell, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 92 - 93
  • [30] Long-Term Safety and Effectiveness of Adalimumab in Children with Moderately to Severely Active Polyarticular or Polyarticular-Course Juvenile Idiopathic Arthritis.
    Brunner, Hermine
    Ruperto, Nicola
    Wallace, Carol A.
    Toth, Mary
    Foeldvari, Ivan
    Bohnsack, John
    Milojevic, Diana
    Rabinovich, C. Egla
    Vavrincova, Pavla
    Kingsbury, Daniel J.
    Marzan, Katherine
    Quartier, Pierre
    Minden, Kirsten
    Chalom, Elizabeth
    Horneff, Gerd
    Kuester, Rolf M.
    Dare, Jason
    Bereswill, Mareike
    Kupper, Hartmut
    Kalabic, Jasmina
    Lovell, Daniel
    Martini, Alberto
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S115 - S116